Clinical Trials Browser

INDUSTRY × Melanoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT02275416 2024-12-16

Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

Phase 1/2 Completed

Melanoma

NCT03538314 2024-08-22

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

Phase 1 Completed

Melanoma

NCT01875653 2019-05-10

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

Phase 3 Terminated

Melanoma